Cavitation Technologies Inc (CVAT) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CVAT Annual Cash Flow →
This cash flow overview for Cavitation Technologies Inc spans from Mar 31 2025 to Mar 31 2026, illustrating how cash generation and usage have shifted across recent reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
9 Months
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Operating Activities
Income-0.95
Depreciation & amortization0.00
Amortization of Other Assets0.01
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories and Other Operating Assets0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.24
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants0.00
Debt Conversion Converted Instrument Amount-
Warrants Issued For Services-
Use Of Advances Against Revenue-
Beneficial Conversion Feature On Convertible Notes Payable-
Fair Value Of Common Stock And Warrants Issued In Exchange Of Fair Value Of Dem and Notes-
Fair Value Of Vested Options And Warrants-
Allowance For Inventory Obsolescence-
Excess Of Fair Value Of Common Stock And Warrants Issued In Exchange For Face Amount Of Dem and Notes-
Fair Value Of Common Stock Issued For Cancelled Options-
Fair Value Of Options Issued To Directors Employees And Consultants-
Patent Writedown-
Operating Lease Right Of Use Asset Amortization Expense-
Fair Value Of Warrants Granted For Services-
Fair Value Of Common Stock Issued For Services Cash Flow-
Loss On Settlement Of Liabilities-
Derivative Liability Movement-0.02
Increase Decrease In Operating Lease Liability-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.01
Increase (Decrease) in Accounts Payable and Accrued Liabilities0.17
Accrued Expense0.00
Increase (Decrease) in Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expenses, Other0.02
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-0.53
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Payments to Acquire Equity Method Investments0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.09
Other borrowing transactions0.00
Long-term debt - borrowings0.06
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.17
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.32
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.53
Total Cash Flow-0.20
4 historic quarters locked

Sign in to unlock the full Cavitation Technologies Inc cash flow history.

About Cavitation Technologies Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001683168-26-004131

Figures are derived from filed reports and may be restated. Historical data is subject to revision.